Navigation Links
CEL-SCI Corporation Releases Letter to Shareholders
Date:2/17/2010

as well as matched tumor samples from head and neck cancer patients not treated with Multikine. The pathologists who participated in this study were blinded to the study and to the patients' clinical outcome.  The results were so impressive that we were able to present the pathology tumor data at ASCO (American Society of Clinical Oncology) and have them published in the very prestigious peer-reviewed Journal of Clinical Oncology.  The promising overall survival data were presented in an oral presentation at the International Conference of Oral Oncology, Amsterdam, 2007 and were published in the peer-reviewed Journal of Oral Oncology.  

The pathology data showed clear clinical benefit to the Multikine-treated patients and suggested that overall patient survival should be improved with Multikine administration.  The longer-term follow-up of the Multikine-treated patients showed that overall survival indeed was improved in these patients.  To avoid any bias, the Multikine survival data in the Phase II trial was compared to the results of all peer reviewed published data available at that time (39 publications).  As time progressed and more publications became available, we updated this comparison and included all of the more recently published peer-reviewed data from these publications (a total of 55 publications).  Our findings of the impact of Multikine administration on the overall survival benefit for these patients still held true.

The safety and efficacy data for Multikine were reviewed by different regulatory agencies, including the US Food and Drug Administration (FDA), prior to giving CEL-SCI clearance to proceed with a global Phase III for Multikine in head and neck cancer.  The open-label, randomized, controlled Phase III study of Multikine in patients with head and neck cancer is designed to demonstrate that Multikine administration to these patients yields
'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
2. CEL-SCI Corporation Releases Letter to Shareholders
3. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
4. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
5. CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase
6. CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
8. CEL-SCI Corporation Announces 2007 Financial Results
9. CEL-SCI Corporation Reports First Quarter Financial Results
10. Data Suggest CEL-SCIs CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis
11. CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)...  Thoratec Corporation (NASDAQ: THOR ), a ... save, support and restore failing hearts, said today it ... On Tuesday, December 2, the company will participate ... Conference.  D. Keith Grossman , President and Chief ... beginning at 11:30 a.m., Eastern Standard Time (8:30 a.m., ...
(Date:11/26/2014)...  Perrigo Company plc ("Perrigo") (NYSE: PRGO ... Healthcare Products®," today announced the closing of Perrigo,s previously ... 6,809,210 ordinary shares at a public offering price of ... option to purchase up to an additional 888,157 ordinary ... Inc., as representatives of the several underwriters. ...
(Date:11/26/2014)... WOODLANDS, Texas , Nov. 26, 2014 /PRNewswire/ ... ) today announced the completion of previously announced ... $280.0 million.  After fees and estimated offering expenses, ... from the transactions.  The transactions consisted of: ... of common stock, pursuant to a registration statement ...
Breaking Medicine Technology:Thoratec Announces Presentations At Investor Conferences For December 2014 2Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 2Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 3Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 4Lexicon Announces Completion Of $280 Million In Financing Transactions 2Lexicon Announces Completion Of $280 Million In Financing Transactions 3
... Multi-Center Phase 1 Trial to Commence -, ... Sheets: ARDC), a company focused on the discovery ... viral,diseases, cancer and inflammatory diseases, today announced that ... status to the,Investigational New Drug (IND) application for ...
... Center of the San Francisco Bay research seeks couples ... ... Reproductive Science Center,of the San Francisco Bay Area, in ... evaluate the safety and effectiveness of,ViaCyte, an investigational product intended ...
Cached Medicine Technology:Ardea Biosciences' Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients 2Ardea Biosciences' Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients 3Bay Area Women Sought for Egg Freezing Study 2
(Date:11/27/2014)... children to help with chores while they are home from ... boosts self-esteem, and above all, helps parents maintain a somewhat ... how do you encourage your children to want to help? ... Child Development Journal, there is. The study found that adults’ ... to lend a hand. , The study found that ...
(Date:11/27/2014)... "The uglier, the better," says Dr. Kirk Kimmerling. ... of laughter as we enjoy the ugly sweater contest." ... from scratch. " It was a sight to see. ... ridiculous enough, the Christmas balls were faces of the staff ... in participating this year, it's simple to get in on ...
(Date:11/27/2014)... India (PRWEB) November 27, 2014 Ethane ... company, has announced online reputation management service. ... a comprehensive study about the world of internet marketing ... and Yahoo. , Ethane Web Technologies does not ... it first analyzes the project to reach a conclusion ...
(Date:11/27/2014)... November 27, 2014 Ethane Web Technologies, an ... will provide a 10% Christmas discount on PPC service. The ... The discount offer will begin on 1 December 2014 and ... About this offer, a PPC professional working at Ethane Web ... for small businesses, as this big discount would make the ...
(Date:11/27/2014)... 26, 2014 Lintelus, Inc., an ... focused on increasing audience engagement at Convergence Summit ... software platform includes a multitude of interactive features ... a collaborative, interactive multi-screen environment. Best of all, ... in real time on their own device. , ...
Breaking Medicine News(10 mins):Health News:Verde Pointe Dental Associates Hosts 2014 Ugly Holiday Sweater Contest 2Health News:Verde Pointe Dental Associates Hosts 2014 Ugly Holiday Sweater Contest 3Health News:Ethane Web Technologies Announces Online Reputation Management Service 2Health News:Ethane Web Technologies Announces 10% Christmas Discount on PPC Service 2Health News:Lintelus Showcases its Feature-Rich Presentation Technology Solution at Convergence Summit’s Annual Event in London 2
... way mothers interact with their babies in the first year ... on. Both a mother,s parenting style and an infant,s temperament ... Lahey and his team from the University of Chicago in ... in Springer,s Journal of Abnormal Child Psychology . , ...
... As part of an initiative to,give back to ... its annual,scientific meetings, the American Society for Therapeutic ... Community - Greater Boston,to raise awareness of cancer ... will join forces with ASTRO by,participating in the ...
... announced today that it has opened a Center for ... Company,s third in the state of,California, one of many ... this location represents the 7th new Center opened in ... According to the National Institute of Health, the ...
... of EP and large untreated patient population to drive ... market, according to Millennium Research Group, ... market will grow significantly over the next five years, ... treatment of cardiac,arrhythmias (a disorder that causes abnormal heart ...
... for Terrorism Preparedness and ... Emergency Response, ... was,selected by the Centers for Disease Control and Prevention (CDC) to ... Emergency Response (COTPER) in Atlanta. This,task order has one base year ...
... N.J., June 23 The American Society of,Transplantation ... the 2008-2009,board of directors. The officers were introduced ... Toronto, Canada, in May., The officers are: ... Medicine; president-elect, Joren C. Madsen, M.D., D.Phil.,Massachusetts General ...
Cached Medicine News:Health News:Mothers' influence is decisive in tots' first year 2Health News:ASTRO, The Wellness Community - Greater Boston Join to Promote Cancer Survivorship 2Health News:CRH Medical Corporation opens Center in San Diego California 2Health News:Chinese Electrophysiology Market to Grow at a CAGR of 20% Over the Next Five Years 2Health News:Lockheed Martin Wins $24 Million IT Contract With CDC 2Health News:The American Society of Transplantation Announces 2008-2009 Board of Directors 2
... PCE PC-Based Exercise ECG Systems offer clinical ... provide advanced database functionality for paperless storage. ... the Welch Allyn PCE Exercise ECG software ... test system. And with its ability to ...
Versatile and Affordable: The Quinton Q-710 ECG system is a versatile and affordable ECG cart that can be configured to meet your specific needs. It can be set on a counter top or mounted on a sturd...
... testing system from Del Mar Reynolds Medical. ... or bicycle ergometer, PC, Cart, isolation transformer ... the same CardioDirect patient interface module that ... ,The system is also available using the ...
... ECT WS 2000 is designed to monitor, store ... provocative tests, (stress-testing). The system can organize the ... provide them for a quick review and printout ... recorded ECG is transmitted via a small portable ...
Medicine Products: